These miRNAs can also target the TGF-β inhibitor Smad7 to activate the TGF-β signalling and induce EMT and tumour initiating cell characteristics downstream of Six1 in human breast cancer [54]. This evidence concerns the gene SIX1 and breast carcinoma.